Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2025-12-24 @ 10:50 PM
NCT ID:
NCT02119169
Eligibility Criteria:
Inclusion Criteria:
* Patients with cirrhotic liver and recurrent pleural effusion.
* Pleural fluid should be transudate according to Light's criteria:
* Pleural fluid-to-serum protein ratio less than 0.5
* Pleural fluid lactic dehydrogenase (LDH) less than 200 IU
* Pleural fluid-to-serum LDH ratio and pleural fluid-to-high normal serum LDH ratio less than 0.6
Exclusion Criteria:
* Diagnosis of hepatocellular carcinoma or other neoplasm able to shorten life expectancy.
* Congestive heart failure.
* Recent (i.e. within the previous 2 weeks) episode of digestive hemorrhage.
* Exudative pleural effusion.
* Ascitic fluid or pleural fluid infection
* Platelet count below 50,000
* Prothrombin activity below 50%
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02119169
Study Brief:
Protocol Section:
NCT02119169